1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
Lupin Ltd.
NSE: LUPIN | BSE: 500257
Mid-range Performer
In 6 Starfolio Baskets
Download real time
US FDA Inspections
Ask AI about Lupin
2062.00 -30.00 (-1.43%)
536.8K
NSE+BSE Volume

NSE 28 Sep, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Lupin receives US FDA nod for its Apixaban Oral Suspension drug, targeting a $3.2 billion market See details

Lupin - LUPIN - stock price prediction, stock forecast, target price, analyst ratings from 36 analysts

Lupin has a share price target of Rs 2477, revenue growth forecast of 8.3%, and profit growth estimate of -17.4% for FY27, based on top 36 analyst calls.

Forecaster Screeners